FDA approves Alzheimer's drug lecanemab amid safety concerns
- PMID: 36627422
- DOI: 10.1038/d41586-023-00030-3
FDA approves Alzheimer's drug lecanemab amid safety concerns
Keywords: Alzheimer's disease; Government; Neuroscience.
Comment on
-
Lecanemab in Early Alzheimer's Disease.N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29. N Engl J Med. 2023. PMID: 36449413 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical